Overexpression of EIF4A3 mRNA is linked to poor prognosis in breast and lung cancer,46 and EIF4A3‐selective inhibitors have been studied as potential cancer therapy with promising results in xenograft mice.47 This evidence concerns the gene EIF4A3 and lung carcinoma.